126 related articles for article (PubMed ID: 2740067)
21. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
22. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
[TBL] [Abstract][Full Text] [Related]
23. Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combination.
Cognetti F; Pinnaro P; Carlini P; Caporali C; Ruggeri EM; Pollera CF
Cancer Chemother Pharmacol; 1984; 13(3):235-7. PubMed ID: 6541533
[TBL] [Abstract][Full Text] [Related]
24. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
25. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
Aasebø U; Slørdal L; Prytz PS; Aarbakke J
Pharmacol Toxicol; 1987 May; 60(5):337-9. PubMed ID: 3303001
[TBL] [Abstract][Full Text] [Related]
26. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
Martín M; Díaz-Rubio E
Med Clin (Barc); 1989 Jun; 93(2):50-3. PubMed ID: 2755259
[TBL] [Abstract][Full Text] [Related]
28. A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen.
Meyer BR; O'Mara V; Reidenberg MM
J Clin Oncol; 1987 Dec; 5(12):1994-7. PubMed ID: 3316518
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model.
Pollera CF; Giannarelli D
Cancer; 1989 Sep; 64(5):1117-22. PubMed ID: 2667749
[TBL] [Abstract][Full Text] [Related]
30. High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer.
Bosnjak SM; Nesković-Konstantinović ZB; Radulović SS; Susnjar S; Mitrovi LB
J Chemother; 2000 Oct; 12(5):446-53. PubMed ID: 11128567
[TBL] [Abstract][Full Text] [Related]
31. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
[TBL] [Abstract][Full Text] [Related]
32. Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
Bécouarn Y; Nguyen BB; David M; Lakdja F; Brunet R; Chauvergne J
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1421-4. PubMed ID: 3595666
[TBL] [Abstract][Full Text] [Related]
33. Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
Pollera CF; Nardi M; Marolla P; Pinnaró P; Terzoli E; Giannarelli D
Am J Clin Oncol; 1989 Dec; 12(6):524-9. PubMed ID: 2589233
[TBL] [Abstract][Full Text] [Related]
34. Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine.
Graham-Pole J; Weare J; Engel S; Gardner R; Mehta P; Gross S
J Clin Oncol; 1986 Jul; 4(7):1110-3. PubMed ID: 3522818
[TBL] [Abstract][Full Text] [Related]
35. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
36. Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
Sorbe B; Hallén C; Skåre NG; Underskog I
Radiother Oncol; 1989 Jun; 15(2):161-7. PubMed ID: 2762589
[TBL] [Abstract][Full Text] [Related]
37. A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin.
Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri N; Nadkarni P; Saikia TK; Gopal R; Advani SH
Cancer; 1988 Nov; 62(10):2263-6. PubMed ID: 3052785
[TBL] [Abstract][Full Text] [Related]
38. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
Donovitz GS; O'Quinn AG; Smith ML
Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
[TBL] [Abstract][Full Text] [Related]
39. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
Roila F
Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
[TBL] [Abstract][Full Text] [Related]
40. A randomised cross-over trial comparing low-dose metoclopramide and chlorpromazine with high-dose metoclopramide in Chinese patients with advanced cancer receiving cisplatinum and 5-fluorouracil.
Shiu W; Tsang V; Lam YM; Zacharia A; Martin WM
Cancer Chemother Pharmacol; 1987; 20(3):259-62. PubMed ID: 3315286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
